Assignee
BLACKMAN RONALD K
US·1 granted patent·9 pending applications·3 citations·filing 2010–2013
Top patents by PatentIndex Score
10 records- 0175US9205086B2Cancer therapy using a combination of a Hsp90 inhibitory compounds and a EGFR inhibitorBLACKMAN RONALD K·Filed 2011·Granted Dec 8, 2015·3 cites·3 claims
- 0246US2014113972A1Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 0340US2012128580A1Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic statusBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 0439US2012128665A1Preselection of subjects for therapeutic treatment based on hypoxic statusBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 0539US2014178366A1Preselection of subjects for therapeutic treatment based on hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 0636US2013156755A1Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitorBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 0734US2014024030A1Preselection of subjects for therapeutic treatment with oxygen sensitive agents based in hypoxic statusBLACKMAN RONALD K·Filed 2013·Application pending·0 cites
- 0831US2014045908A1Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancersBLACKMAN RONALD K·Filed 2012·Application pending·0 cites
- 0929US2013171105A1Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitorBLACKMAN RONALD K·Filed 2011·Application pending·0 cites
- 1028US2012245186A1Combination cancer therapy with hsp90 inhibitory compoundsBLACKMAN RONALD K·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →